Public disclosure of potential incollectibility of a loan of 3,000 thousand yen held by consolidated subsidiary Axel Medic\u0430. Expectation to record allowance for loan losses within the current term; sales in Beauty & Wellness business projected to temporarily approach zero due to dissolution and special liquidation of the subsidiary.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3624","jir_company_name":"Aceler Market Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/3624-20260917-03.pdf","jir_short_summary":"Public disclosure of potential incollectibility of a loan of 3,000 thousand yen held by consolidated subsidiary Axel Medic\u0430. Expectation to record allowance for loan losses within the current term; sales in Beauty & Wellness business projected to temporarily approach zero due to dissolution and special liquidation of the subsidiary.","jir_summary":"### Key points of the news\nAxel Mark Co., Ltd.'s wholly owned subsidiary Axel Medic\u0430 Co., Ltd. publicly discloses the potential incollectibility of a loan of 3,000 thousand yen. The process of recording allowances and decisions on dissolution and special liquidation are underway, and sales of the Beauty & Wellness business are expected to temporarily decline significantly until recovery.\n\n### Future actions and impact\nAs an impact on the consolidated accounts, the related receivable is planned to be fully recognized as an allowance for loan losses or as a loan loss in fiscal 2026. Review internal credit judgment, lending procedures, and monitoring framework, and promptly implement preventive measures. Due to the dissolution and special liquidation of Axel Medic\u0430, sales of the core business in the group\u2019s growth strategy are expected to temporarily drop to near zero.","jir_financial_highlights":"Loans: 3,000 thousand yen (Not stated)\nRatio to consolidated net assets: 0.37% (YoY information not stated)\nMaturity date: August 18, 2026 (elapsed)","jir_category":"","jir_hashtags":"#AxelMark, #IRDisclosureAdditional","jir_key_figures":"Loans: 3,000 thousand yen (risk amount of incollectibility)\nRatio to consolidated net assets: 0.37\uff05\nMaturity date: August 18, 2026","jir_meta_title":"\u3010Axel Mark\u3011Disclosure of potential incollectibility of consolidated subsidiary's receivables | 2026-09-17","jir_meta_description":"Disclosure of the risk of incollectibility for Axel Medic\u0430's loan of 3,000 thousand yen. Expect to record allowance for loan losses this term; implement business restructuring and recurrence prevention measures. Please refer to the notice for details.","jir_og_title":"\u3010Axel Mark\u3011Disclosure of potential incollectibility of consolidated subsidiary's receivables | 2026-09-17","jir_og_description":"Disclosure of incollectibility risk for Axel Medic\u0430's loan of 3,000 thousand yen and future outlook. Explains dissolution and special liquidation policy decisions and impact on business sales.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":61292,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"disclosure_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-114804","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n